Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Rheumatoid Arthritis

  Free Subscription


19.07.2021

2 Arthritis Res Ther
7 Clin Exp Rheumatol
2 Clin Rheumatol
1 Intern Med
1 J Immunol
1 Rheumatol Int
1 Scand J Rheumatol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Arthritis Res Ther

  1. ANDONIAN BJ, Johannemann A, Hubal MJ, Pober DM, et al
    Altered skeletal muscle metabolic pathways, age, systemic inflammation, and low cardiorespiratory fitness associate with improvements in disease activity following high-intensity interval training in persons with rheumatoid arthritis.
    Arthritis Res Ther. 2021;23:187.
    PubMed         Abstract available

  2. STOCKFELT M, Lundell AC, Hetland ML, Ostergaard M, et al
    Plasma interferon-alpha is associated with double-positivity for autoantibodies but is not a predictor of remission in early rheumatoid arthritis-a spin-off study of the NORD-STAR randomized clinical trial.
    Arthritis Res Ther. 2021;23:189.
    PubMed         Abstract available


    Clin Exp Rheumatol

  3. PULITO-CUETO V, Remuzgo-Martinez S, Genre F, Calvo-Alen J, et al
    Role of adiponectin in non-diabetic patients with rheumatoid arthritis undergoing anti-IL-6 therapy.
    Clin Exp Rheumatol. 2021 Jul 7. pii: 17208.
    PubMed         Abstract available

  4. MONA M, Mondello S, Hyon JY, Saleh W, et al
    Clinical usefulness of anti-muscarinic type 3 receptor autoantibodies in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39:795-803.
    PubMed         Abstract available

  5. CACCIAPAGLIA F, Renna D, Fornaro M, Venerito V, et al
    Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre.
    Clin Exp Rheumatol. 2021 Jun 25. pii: 16172.
    PubMed        

  6. ALVARO GRACIA JM, Barbazan C, Garcia Llorente JF, Munoz-Fernandez S, et al
    Local adaptation of recommendation-based materials for shared decision-making and management of comorbidity in rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jun 26. pii: 17046.
    PubMed         Abstract available

  7. MATSUNO H, Kang YM, Okada M, Lee SI, et al
    Comparison of the efficacy and safety of LBAL, a candidate adalimumab biosimilar, and adalimumab reference product in patients with active rheumatoid arthritis inadequately responding to methotrexate: a 52-week phase III randomised study.
    Clin Exp Rheumatol. 2021 Jul 7. pii: 16868.
    PubMed         Abstract available

  8. YOSHIZAWA Y, Nakao T, Tsuritani K, Yamada T, et al
    The importance of specific citrullinated clusterin and vimentin found in a multi-coloured bead-based citrulline-peptide array system in rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jul 8. pii: 16877.
    PubMed         Abstract available

  9. BOLETO G, Cren JB, Avouac J, Allanore Y, et al
    Successful treatment with baricitinib of refractory arthritis in a patient with severe diffuse cutaneous systemic sclerosis-rheumatoid arthritis overlap syndrome.
    Clin Exp Rheumatol. 2021 Jun 15. pii: 17277.
    PubMed        


    Clin Rheumatol

  10. MORRIS NT, Brook J, Ben-Artzi A, Martin W, et al
    Doppler ultrasound impacts response to intravenous tocilizumab in rheumatoid arthritis patients.
    Clin Rheumatol. 2021 Jul 16. pii: 10.1007/s10067-021-05857.
    PubMed         Abstract available

  11. POTERA J, Kambhatla S, Gauto-Mariotti E, Manadan A, et al
    Incidence, mortality, and national costs of hospital admissions for potentially preventable infections in patients with rheumatoid arthritis.
    Clin Rheumatol. 2021 Jul 12. pii: 10.1007/s10067-021-05836.
    PubMed         Abstract available


    Intern Med

  12. SHIMA N, Kokuzawa A, Saito K, Kamata Y, et al
    Immune Reconstitution Inflammatory Syndrome Associated with Pneumocystis Jirovecii Pneumonia and Cytomegalovirus Colitis in a Patient with Rheumatoid Arthritis.
    Intern Med. 2021 Jul 10. doi: 10.2169/internalmedicine.7176.
    PubMed         Abstract available


    J Immunol

  13. CARVAJAL ALEGRIA G, Cornec D, Saraux A, Devauchelle-Pensec V, et al
    Abatacept Promotes Regulatory B Cell Functions, Enhancing Their Ability to Reduce the Th1 Response in Rheumatoid Arthritis Patients through the Production of IL-10 and TGF-beta.
    J Immunol. 2021 Jul 9. pii: jimmunol.2000455. doi: 10.4049/jimmunol.2000455.
    PubMed         Abstract available


    Rheumatol Int

  14. HONNE K, Bando M, Mieno MN, Iwamoto M, et al
    Bronchiectasis is as crucial as interstitial lung disease in the severe pneumonia that occurs during treatment with biologic DMARDs in rheumatoid arthritis: a retrospective cohort study in a single facility.
    Rheumatol Int. 2021 Jul 12. pii: 10.1007/s00296-021-04934.
    PubMed         Abstract available


    Scand J Rheumatol

  15. VUOLTEENAHO K, Tuure L, Nieminen R, Laasonen L, et al
    Pretreatment resistin levels are associated with erosive disease in early rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs and infliximab.
    Scand J Rheumatol. 2021 Jul 15:1-6. doi: 10.1080/03009742.2021.1929456.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: